SCHEMBL766233

SCHEMBL766233

CC(=O)OC(C)CC(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
CHRM2 P08172 1/20 0.56
CHRM4 P08173 1/20 0.56
CHRM1 P11229 1/20 0.56
TBXA2R P21731 1/20 0.56
GALR3 O60755 1/20 0.54
MAPT P10636 1/20 0.54
BLM P54132 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CYP19A1 P11511 1/20 0.41
ALOX15 P16050 1/20 0.40
ALDH1A1 P00352 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
RNPEP Q9H4A4 1/20 0.39
SLC7A5 Q01650 1/20 0.39
ANPEP P15144 3/20 0.37
LAP3 P28838 2/20 0.37
ERAP1 Q9NZ08 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
CACNB3 P54284 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14087827 1.00 TSHR (0.56) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL10331178 0.92 TSHR (0.58) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL3751182 0.84 TSHR (0.52) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL8958912 0.82 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL5478726 0.82 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL17486681 0.82 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL17358635 0.82 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL756656 0.81 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL13424251 0.80 TSHR (0.48) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL10793944 0.80 TSHR (0.58) TSHRCHRM2CHRM4CHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122065904-A Countermeasure strategy method based on double-layer diagram attention network and deep reinforcement learning 电子科技大学长三角研究院(衢州) 2026-05-19 CN claimed
US-12624174-B2 Hydrogen-bond enriched ion exchange membranes THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2026-05-12 US claimed
EP-4663786-A1 A METHOD FOR RECOVERING A COMPONENT FROM A PEROVSKITE STRUCTURE Saule S.A. (PL) 2025-12-17 EP claimed
US-20250136862-A1 LIGHT EMITTING ELEMENT, DISPLAY DEVICE INCLUDING THE LIGHT EMITTING ELEMENT, AND METHOD OF MANUFACTURING THE LIGHT EMITTING ELEMENT SAMSUNG DISPLAY CO., LTD. (KR) 2025-05-01 US claimed
CN-119799314-A Application of organic strong acid ligand in regulating and controlling perovskite nanocrystalline halogen activity 浙江大学 2025-04-11 CN claimed
CN-119788702-A Fusion AoI and intrinsic stimulated MEC system multi-agent collaboration framework 哈尔滨工业大学 2025-04-08 CN claimed
CN-116836304-B Anti-freeze-thawing hydrolysis-resistant ASA papermaking sizing agent emulsion and preparation method thereof 齐鲁工业大学(山东省科学院) 2025-03-25 CN claimed
CN-119677382-A Full perovskite laminated solar cell and preparation method and application thereof 南京工业大学 2025-03-21 CN claimed
WO-2025048318-A1 FUEL CELL HUMIDIFIER OF WHICH HOLLOW FIBER MEMBRANES CAN BE LENGTH-ADJUSTED, AND FUEL CELL HUMIDIFIER OF WHICH GAPS BETWEEN HOLLOW FIBER MEMBRANES CAN ADJUSTED 코오롱인더스트리 주식회사 2025-03-06 WO claimed
CN-119561174-A Power distribution network reactive power optimization method based on data enhancement and hybrid enhancement intelligence 华南理工大学 2025-03-04 CN claimed
CN-1976887-A Process for the preparation of alkoxylation catalysts and their use in alkoxylation processes HARCROS CHEMICALS INC (US) 2007-06-06 CN claimed
EP-1747183-A2 METHOD OF PREPARING ALKOXYLATION CATALYSTS AND THEIR USE IN ALKOXYLATION PROCESSES Harcros Chemicals Inc. (US) 2007-01-31 EP claimed
US-7119236-B2 Method of preparing alkoxylation catalysts and their use in alkoxylation processes HARCROS CHEMICALS INC. (US) 2006-10-10 US claimed
US-6969712-B2 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-29 US claimed
WO-2005104774-A2 METHOD OF PREPARING ALKOXYLATION CATALYSTS AND THEIR USE IN ALKOXYLATION PROCESSES HARCROS CHEMICALS INC. (US) 2005-11-10 WO claimed
US-20050240064-A1 Method of preparing alkoxylation catalysts and their use in alkoxylation processes HARCROS CHEMICALS INC. 2005-10-27 US claimed
US-20050209355-A1 [Novel Reactions and the Products of Such Reactions] ROITMAN LIPA L 2005-09-22 US claimed
US-20040044056-A1 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-03-04 US claimed
EP-1342717-A1 BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-09-10 EP claimed
WO-2001023274-A1 DETERGENT PACKAGE WITH MEANS TO MASK AMINE MALODOURS THE PROCTER & GAMBLE COMPANY (US) 2001-04-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624174-B2 Hydrogen-bond enriched ion exchange membranes SLC9A2, SLC9A3, SLC9A1 TSHR 1470/4885CHRM2 1356/4885CHRM4 2380/4885
US-20040044056-A1 Benzimidazole derivatives GPR119, OPRL1, INSR TSHR 239/4885CHRM2 458/4885CHRM4 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.